Keyphrases
Mitogen-activated Protein Kinase
100%
Antileukemic Activity
100%
Kinase Cascade
100%
Dasatinib
100%
BCR-ABL
50%
Leukemia
25%
Cellular Events
12%
Pharmacological Inhibitors
12%
Cell-derived
12%
Patient-derived
12%
Inhibitory Effect
12%
Abl Tyrosine Kinase
12%
Colony Forming Units
12%
Apoptotic Cells
12%
Resistant mutants
12%
SiRNA Knockdown
12%
Antiproliferative Activity
12%
Kinase Inhibition
12%
Kinase Activation
12%
Tyrosine Kinase Inhibitor
12%
Cell Cycle Arrest
12%
Imatinib Mesylate
12%
Imatinib Resistance
12%
Growth in Vitro
12%
Mixed Lineage Kinase
12%
KT-1
12%
MSK1
12%
Abl Kinase
12%
Via Resistance
12%
T315I
12%
MKK3
12%
T315I mutation
12%
Biochemistry, Genetics and Molecular Biology
Mitogen-Activated Protein Kinase
100%
Dasatinib
100%
Kinase
25%
Phosphotransferase
25%
Imatinib
25%
Small Interfering RNA
12%
Tyrosine Kinase Inhibitor
12%
Colony Forming Unit S
12%
Upregulation
12%
Cell Cycle Checkpoint
12%
Cell Cycle Arrest
12%
Antiproliferative Activity
12%